Myeloid Sarcoma Predicts Superior Outcome in Pediatric AML; Can Cytogenetics Solve the Puzzle?
ConclusionAlthough t (8; 21) was more frequently associated with MS, it did not appear to be the reason for better outcome.
Source: Clinical Lymphoma Myeloma and Leukemia - Category: Cancer & Oncology Source Type: research
More News: Acute Leukemia | Acute Myeloid Leukemia | Cancer | Cancer & Oncology | Leukemia | Lymphoma | Myeloma | Pediatrics | Sarcomas | Study